CN106053783A - Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit - Google Patents

Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit Download PDF

Info

Publication number
CN106053783A
CN106053783A CN201610392936.2A CN201610392936A CN106053783A CN 106053783 A CN106053783 A CN 106053783A CN 201610392936 A CN201610392936 A CN 201610392936A CN 106053783 A CN106053783 A CN 106053783A
Authority
CN
China
Prior art keywords
test
reaction cup
tuberculosis
gamma interferon
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610392936.2A
Other languages
Chinese (zh)
Inventor
谭玉华
范主桥
岑柏坚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Fenghua Bioengineering Co Ltd
Original Assignee
Guangzhou Fenghua Bioengineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Fenghua Bioengineering Co Ltd filed Critical Guangzhou Fenghua Bioengineering Co Ltd
Priority to CN201610392936.2A priority Critical patent/CN106053783A/en
Publication of CN106053783A publication Critical patent/CN106053783A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)

Abstract

The invention discloses a quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis. The kit is characterized by comprising 1) a test reaction cup; 2) a calibrator reaction cup; 3) a blank control culture tube containing an anticoagulant substance inside; 4) a test culture tube; 5) a positive control culture tube containing an anticoagulant substance and cell agglutinin inside; 6) an experiment buffer solution and 7) a wash concentrate. The invention further discloses a detection method of the quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis. The kit adopts a gamma-interferon in-vitro release method, a biotin-avidin method and double-antibody sandwich time-resolved fluorescence immunoassay together, the experimental methods are simple and quick, automatic operation is realized, and the detection system is an open type operation system.

Description

A kind of rapid time resolved fluorometric immunity being applicable to the detection of tuberculosis infection T cell divides Analysis test kit and detection method thereof
Technical field
The invention belongs to medicine and hygiene fields, particularly relate to a kind of rapid time being applicable to the detection of tuberculosis infection T cell Resolved fluorometric immunoassay kits and detection method thereof.
Background technology
Tuberculosis is by the mycobacterium tuberculosis (Mycobacterium in mycobacterium tuberculosis complex Tuberculosis, MTB), Mycobacterium bovis (Mycobacterium bovis) and mycobacterium africanum (Mycobacterium Africanum) chronic infectious disease caused, can involve each organ of whole body, especially the most common with pulmonary tuberculosis.Tuberculosis branch Bacillus is usually and is passed through air droplet infection to new host by respiratory tract tuberculosis patient.Incubation period lungy is that several weeks are to number Month, period major part the infected non-evident sympton.Tuberculosis serious harm public safety, the whole world has 2,000,000 people to die from every year Tuberculosis.In China, there is the newly-increased tuberculosis patient of 1,000,000 every year.
The microscopy of mycobacterium tuberculosis is the method for the most frequently used diagnosis of tuberculosis, but the positive rate of the method is low.Knot The cultivation of core mycobacteria determines that goldstandard lungy, but owing to the speed of growth of mycobacterium tuberculosis is slow, test week Phase length (2~3 weeks), it is impossible to meet clinical requirement.It addition, tuberculosis can also pass through Chest X-rays, detection of nucleic acids, physical examination etc. Method confirms.The infection of latent tuberculosis bacterium is a kind of special state after host infection mycobacterium tuberculosis, in the infected's body Mycobacterium tuberculosis is in retention-state, it is impossible to is diagnosed as active tuberculosis, but has the wind developing into active tuberculosis Danger.The high-risk group infecting latent tuberculosis bacterium carries out early diagnosis and suitably intervenes, and has actively in Tubercufosis control Meaning.Tuberculin test is uniquely to diagnose the method that latent tuberculosis bacterium infects, after mycobacterium tuberculosis infection 2~10 weeks Interior tuberculin test transfers the positive to.But, some the infected is responseless to tuberculin, both includes in these crowds Those of a variety of causes causes immunosuppressant, also include that some do not have immunosuppressant people.Additionally, bcg vaccination, infect non- Pathogenic mycobacterium, and other factors, can cause non-tubercle bacillus affection person's tuberculin test positive.
The gamma interferon release in vitro method of tuberculosis infection T cell (interferon-gamma release Assays, IGRAs) detection is cell mediated immunity (the cell mediated caused by mycobacterium tuberculosis specific antigen Immunity, CMI) reaction realizes.The antigen of the test kit use of listing at present or polypeptide or its analog mainly have early Phase secretion antigen target protein 6 (early secreting antigen target 6, ESAT6), culturing filtrate protein 10 One or more in (culture filtrate protein-10, CFP-10) and TB7.7 (p4) etc. are as differential stimulus Antigen, the non-tuberculous mycobacteria [mycobacterium kansasii (Mycobacterium of all of strain of BCG vaccine and the overwhelming majority Kansasii), Suhl adds mycobacteria (Mycobacterium szulgai), Hai Shi mycobacteria (Mycobacterium Marinum) except] do not contain these protein.The blood of the patient infecting mycobacterium tuberculosis complex usually contains energy Enough identifying the lymphocyte of these protein and other antigen of mycobacterium, this identification process is along with the conjunction of gamma interferon Become and secretion.IGRAs utilizes Specific Antigen of Mycobacterium Tuberculosis or polypeptide or its analog to stimulate the knot in people's whole blood sample Core antigen of mycobacterium specific T-cells produces immunne response, then quantitative determines immunity in human serum by the method for immunoassay The concentration of the gamma interferon that response produces, thus judge that the T cell immunity whether experimenter has mycobacterium tuberculosis special is anti- Should, i.e. tuberculosis infection T cell detection.Gamma interferon is a kind of cytokine of Th1 emiocytosis, is not only able to reflect body The Th1 cellular immunization situation of tuberculosis, also closely related with the antigenic content of internal tulase.By antigen of mycobacterium tuberculosis sensitization T cell can produce high-caliber gamma interferon when running into cognate antigen again, be therefore used for the diagnosis of tuberculosis latent infection.
Summary of the invention
It is an object of the invention to provide a kind of rapid time resolved fluorometric immunity being applicable to the detection of tuberculosis infection T cell Assay kit, have employed gamma interferon release in vitro method, combines the biotin-labeled pentylamine method that have employed, double-antibody sandwich time Resolved fluorometric immunization, experimental technique is simple and quick, can automation mechanized operation, detecting system is open operating system.
The technical solution used in the present invention is: a kind of rapid time resolved fluorometric being applicable to the detection of tuberculosis infection T cell Immunoassay kits, including: 1) test reaction cup, its endoperidium has Streptavidin and is combined on Streptavidin Biotinylation gamma interferon monoclonal antibody, and the gamma interferon monoclonal antibody containing lanthanide series labelling;2) calibration object Reaction cup, its endoperidium has Streptavidin and the biotinylation gamma interferon monoclonal anti being combined on Streptavidin Body, and containing europium labelling gamma interferon monoclonal antibody and the calibration object of variable concentrations;3) blank culture tube, it includes There is anticoagulative substance;4) test cultures pipe, it is contained within anticoagulative substance and can stimulate antigen of mycobacterium tuberculosis specificity T Cell produces the stimulus object of gamma interferon, stimulus object be the antigen of mycobacterium tuberculosis and derivative epitope peptide thereof and it Analog at least one;5) positive control culture tube, it is contained within anticoagulative substance and cell agglutinin;6) experiment Buffer;And 7) concentrate washing liquid.
The principle of the test kit of the present invention is: use gamma interferon release in vitro method and Time-resolved Fluoimmunoassay inspection Survey the cell mediated immune response that mycobacterium tuberculosis specific antigen is caused;By mycobacterium tuberculosis specific antigen, polypeptide Or their analog stimulates the T lymphocyte specific of m tuberculosis infection person and makes it breed, discharges γ-interference Element;Be coated with in the reaction cup of Streptavidin connection biotinylation gamma interferon monoclonal antibody, and containing europium labelling γ- Interferon monoclonal antibody is as test reaction cup, and in one group of reaction cup, the gamma interferon antigen possibly together with variable concentrations is made For calibration object reaction cup, add sample in the relevant position of test reaction cup, then in calibration object reaction cup with added with sample Test reaction cup adds test buffer, oscillation incubation, washing, dry reaction cup, utilizes time resolved fluoro-immunoassay Instrument detection fluorescent value, fluorescent value intensity is directly proportional to the gamma interferon content in calibration object or sample.
Preferably, the gamma interferon monoclonal antibody of described lanthanide series labelling is europium labelling gamma interferon monoclonal anti Body.
Preferably, described stimulus object be mycobacterium tuberculosis Rv0733, Rv1978, Rv1980 (MPT64), Rv1981c, Rv1984(CFP-21)、Rv1985c、Rv2654c(TB7.7)、Rv3425、Rv3429、Rv3615c(ESPC)、Rv3873、 Rv3874 (CFP-10), Rv3875 (ESAT-6), Rv3878, Rv3879c antigen, their derivative epitope peptide, chimeric weight At least one in group antigen and the like;Described stimulus object content in test cultures pipe is 1~10 μ g/mL, μ here G/mL refers to the pre-whole blood added relative in every milliliter of test cultures pipe, and the content of described stimulus object is 1~10 μ g.
It is highly preferred that described stimulus object is Rv3874 (CFP-10) and the compositions of Rv3875 (ESAT-6);Wherein, The mass ratio of Rv3874 (CFP-10) and Rv3875 (ESAT-6) is 1:1.Rv3874 (CFP-10) and Rv3875 (ESAT-6) is Special advantage stimulus object, using effect is more preferably.
Preferably, described anticoagulative substance is heparin sodium and/or Lithium acid heparin;Described blank pipe, test cultures pipe and Containing heparin sodium or the Lithium acid heparin of 9.8~28IU/mL blood in positive control culture tube respectively, IU/mL blood here refers to relatively The pre-whole blood added in every milliliter of test cultures pipe, the content of described anticoagulative substance is 9.8~28IU.
Preferably, described cell agglutinin is phytohemagglutinin and/or ConA (ConA), more preferably Phytohaemagglutinin L.
Preferably, described cell agglutinin content in described positive control culture tube is 1~20 μ g/mL, μ here G/mL refers to the pre-whole blood added relative in every milliliter of test cultures pipe, and the content of described cell agglutinin is 1~20 μ g.
Preferably, described test buffer is the sodium chloride containing 0.15mol/L, the tween 20 of 0.6mL/L, 30ppmPreservative, the 4-hydroxyethyl piperazine ethanesulfonic acid of 5mmol/L, pH7.8 of ethylenediaminetetraacetic acid of 100 μm ol/L Buffer;
Described concentration washing liquid is the sodium chloride containing 1.125g/L, the tween 20 of 0.2mL/L, 30ppmThe tris-HCI buffer of the 50mmol/L of preservative, pH7.8.
Preferably, the preparation method of described test reaction cup is: described Streptavidin is diluted to concentration 0.1~10 μ G/mL, joins in skip test reaction cup, hatches 20~24h, washing at 2~8 DEG C;By described biotinylation gamma interferon Monoclonal antibody is diluted to concentration 0.1~10 μ g/mL, joins in the test reaction cup being coated with Streptavidin, 2~8 DEG C Under hatch 20~24h, washing;The most each cup adds sealing coat solution, forms sealing coat after drying, finally on sealing coat Add the gamma interferon monoclonal antibody of described lanthanide series labelling that working concentration is 100~400ng/mL, after drying and get final product Described test reaction cup.It is highly preferred that the gamma interferon monoclonal antibody of described lanthanide series labelling is europium labelling γ-interference Element monoclonal antibody.
It is highly preferred that the sealing coat solution that described sealing coat uses is the sodium chloride containing 0.12mol/L, 0.38g/L Sodium azide, the cattle gamma Globulin of 10g/L, the bovine serum albumin of 50g/L, the trehalose of 50g/L, 0.8g/L aboriginal mouse IgG, Degeneration mouse IgG, 2g/L casein of 0.05g/L, the trihydroxy methyl ammonia of 50mmol/L, pH7.8 of heparin sodium of 37.5U/mL Methylmethane-hydrochloric acid.
It is highly preferred that sealing coat solution is dried refers to dried overnight under (36 ± 1) DEG C, 5% damp condition;Europium labelling Gamma interferon monoclonal antibody is dried and refers to dry up under 60 DEG C of hot blasts.
It is highly preferred that wherein the solution of dilution Streptavidin and biotinylation gamma interferon monoclonal antibody is The phosphate buffer of 50mmol/L, pH7.8.
It is highly preferred that wherein the solution of dilution europium labelling gamma interferon monoclonal antibody is the chlorination containing 150mmol/L Sodium, the sodium azide of 0.5g/L, the deionization bovine serum albumin of 2g/L, 125g/L trehalose 50mmol/L, pH7.8 three Hydroxymethyl aminomethane-hydrochloric acid.
It is highly preferred that europium labelling gamma interferon method for preparing monoclonal antibody therein is, labelling gamma interferon list Liquid NAP-10 post in clonal antibody is replaced as the carbonate buffer solution of 50mmol/L, pH9.0, and makes the dense of traget antibody Degree reaches 2~5mg/mL, and the 4-[2-(4-isothiocyanatophenyl) acetenyl]-2 of the europium with 3 times of quality, 6 pairs of { [double (carboxylics of N, N Methyl)-amino] methyl } pyridine reagent is blended in oscillation incubation (22 ± 2) h, reactant liquor 50mmol/L, pH at 2~8 DEG C Sepharose CL-6B post (1cm × 40cm) chromatography of 7.80 tris-HCI buffer balances, respectively Albumen eluting peak is collected in A280 monitoring.
Preferably, the preparation method of described calibration object reaction cup is: described Streptavidin is diluted to concentration 0.1~10 μ g/mL, joins in blank calibration object reaction cup, hatches 20~24h, washing at 2~8 DEG C;By described biotinylation γ-interference Element monoclonal antibody be diluted to concentration 0.1~10 μ g/mL, join in the calibration object reaction cup being coated with Streptavidin, 2~ 20~24h are hatched, washing at 8 DEG C;The most each cup adds sealing coat solution, forms sealing coat after drying, on sealing coat Add the gamma interferon monoclonal antibody of the described lanthanide series labelling that working concentration is 100~400ng/mL, formed after drying The gamma interferon monoclonal antibody layer of lanthanide series labelling, the gamma interferon monoclonal of the lanthanide series labelling in each cup Add the calibration object of variable concentrations on antibody layer, the most i.e. obtain calibration object reaction cup.It is highly preferred that the concentration of described calibration object Be respectively 0,6,300,15000pg/mL;The every concentration of calibration object arranges 2, and vacuum is crossed and moulded packaging, and 2~8 DEG C save backup.Every Absciss layer solution is dried and refers to dried overnight under (36 ± 1) DEG C, 5% damp condition;The gamma interferon Dan Ke of lanthanide series labelling Grand antibody and calibration object are dried and refer to dry up under 60 DEG C of hot blasts.It is highly preferred that the gamma interferon list of described lanthanide series labelling Clonal antibody is europium labelling gamma interferon monoclonal antibody.The preparation method of described calibration object is: with United Kingdom National biological product Calibrating institute (National Institute for Biological Standards and Control, NIBSC) numbering 87/ The gamma interferon biological reference material (1IU/mL ≈ 50pg/mL) of 586 is comparison, by Human Lymphobl Toid Interferon antigen step 1) the sealing coat solution in is diluted to 0, the calibration object of 6,300,15000pg/mL.
Preferably, the preparation method of described blank culture tube is: add in clean test tube (plastics or glass) The heparin sodium of 9.8~28IU/mL blood or Lithium acid heparin;Test tube is uprightly put in full-automatic vacuum-pumping capping machine, true in making test tube Idling pressure.
Preferably, the preparation method of described test cultures pipe is: add in clean test tube (plastics or glass) 9.8~ The heparin sodium of 28IU/mL blood or Lithium acid heparin, and Rv0733, Rv1978, Rv1980c (MPT64) of 1~10 μ g/mL, Rv1981c、Rv1984c(CFP-21)、Rv1985c、Rv2654c(TB7.7)、Rv3425、Rv3429、Rv3615c(ESPC)、 One or more antigens in Rv3873, Rv3874 (CFP-10), Rv3875 (ESAT-6), Rv3878, Rv3879c or polypeptide or Its analog or its chimeric recombinant antigens;Test tube is uprightly put in full-automatic vacuum-pumping capping machine, makes negative pressure of vacuum in test tube.
Preferably, the preparation method of described positive control culture tube is: add in clean test tube (plastics or glass) The heparin sodium of 9.8~28IU/mL blood or Lithium acid heparin, and the phytohemagglutinin (PHA) of 1~20 μ g/mL or Semen Canavaliae coagulate Collection element (ConA).Test tube is uprightly put in full-automatic vacuum-pumping capping machine, makes negative pressure of vacuum in test tube.
The lid of culture tube contains Nei Sai and it mates outer safety helmet, it is preferable that described blank culture tube, test training The outer safety helmet color supporting pipe and positive control culture tube is different.It is highly preferred that the outer peace of described blank culture tube Full cap color is green;The outer safety helmet color of described test cultures pipe is yellow;The outer safety of described positive control culture tube Cap color is red.
Present invention also offers the described rapid time resolved fluorometric immunoassay being applicable to the detection of tuberculosis infection T cell The detection method of test kit, comprises the following steps:
(1) add entirely in blank culture tube, test cultures pipe and three kinds of culture tubes of positive control culture tube respectively Blood sample, and reverse make the content in whole blood sample and three kinds of culture tubes mix for several times;
(2) three kinds of culture tubes added with whole blood sample are placed at 35~38 DEG C upright cultivation 16~24 hours;
(3), after cultivation terminates, by centrifugal, blood plasma in the whole blood sample of three kinds of culture tubes is separated;
(4) that presets in calibration object reaction cup tests buffering containing being separately added in the hole of the calibration object of variable concentrations Liquid, and by step 3) in blood plasma in the whole blood sample that separates and test buffer add in test reaction cup;
(5) by calibration object reaction cup and test reaction cup at 30~40 DEG C, oscillation incubation 5~20min;
(6) washing, dried, use time-resolved fluorescence immunoassay instrument to carry out fluorescent value counting.
Preferably, in described step (3), it is centrifuged and refers to be centrifuged under the rotating speed of 3000~5000r/min 10~20min;
In described step (6), it is dried and refers to be dried under 50~70 DEG C of hot blasts 30~40s.
Relative to prior art, the invention have the benefit that
The present invention uses dry reagent rapid time resolved fluorometric immuno analytical method, solves conventional Conventional Time and differentiates Fluorescence immunoassay technology reagent component is various, and liquid reagent is not sufficiently stable, complex operation, the longest shortcoming.And this Invention solves during conventional tuberculosis infection T cell measures needs independent blood taking tube and culture tube, trivial operations, easily go out The shortcomings such as mistake, automaticity are the highest;Present invention achieves blood taking tube and culture tube integration, negative pressure of vacuum is accurately taken a blood sample;3 kinds Culture tube uses different colours label and cap to make a distinction;Avoid during whole blood cell culture blood taking tube uncap, subpackage blood sample, The processes such as secondary marker, it is therefore prevented that sample is uncapped at blood taking tube, secondary pollution during subpackage blood sample, during decreasing this Potential bio-safety risk, also prevent secondary marker process produce mistake, as long as and after whole blood cell culture routinely from I.e. can be placed in after the heart and on fully automatic system, be sampled detection, reduce working strength and improve work efficiency.The present invention Culture tube have blood taking tube and culture tube integration, blood collection procedure decreases consumptive material uses, vacuum is accurately taken a blood sample, be suitable to from The features such as dynamicization operation.The test kit of the present invention has testing result accuracy, highly sensitive, high specificity, good stability, inspection The features such as survey method is easy, efficient, are suitable for real-time test (point-of-care testing, POCT).
Accompanying drawing explanation
Fig. 1 is the gamma interferon detection by quantitative dose-response curve of test kit of the present invention.
Detailed description of the invention
For better illustrating the object, technical solutions and advantages of the present invention, below in conjunction with specific embodiment to the present invention It is described further.
Streptavidin in following example is purchased from Shenzhen Fei Peng limited company;Biotin labeling gamma interferon Monoclonal antibody is purchased from MabTech company of Holland;Labelling gamma interferon monoclonal antibody is purchased from Xiamen Wan Taikairui biology skill Art company limited;Rv0733、Rv1978、Rv1980c(MPT64)、Rv1981c、Rv1984c(CFP-21)、Rv1985c、 Rv2654c(TB7.7)、Rv3425、Rv3429、Rv3615c(ESPC)、Rv3873、Rv3874(CFP-10)、Rv3875(ESAT- 6), Rv3878, Rv3879c antigen or polypeptide or its analog or its chimeric recombinant antigens are purchased from Sigma Co., USA;Plant blood Solidifying element L (phytohaemagglutinin-L, PHA-L) is purchased from Sigma Co., USA;4-[the 2-(4-isothiocyanatophenyl) of europium Acetenyl]-2,6 pairs of { [double (the carboxymethyl)-amino of N, N] methyl } pyridine reagent are purchased from PerkinElmer company of the U.S.;Blank anti- Cup is answered to be purchased from Nunc company of Denmark;The gamma interferon biological reference material of numbering 87/586 is purchased from United Kingdom National biological product Calibrating institute;Agarose gel Sepharose CL-6B is purchased from Pharmacia Inc., Sweden;Washing liquid, test buffer, FWZ-I type Trace shaker, the full-automatic Enzyme-linked washing-board of DEM-III type are provided by Guangzhou City Fenghua Biological Engineering Co., Ltd; VictorTM2D1420 type TRFIA instrument is purchased from Perkin Elmer company of the U.S.;AQT90FLEX rapid immunoassay instrument is purchased from pellet Wheat Radiometer company.Other reagent are domestic analytical pure;Tuberculosis infection T cell detection kit (exempt from by release in vitro enzyme connection Epidemic disease method) it is purchased from Beijing Wantai Biological Pharmacy Enterprise Co., Ltd..
Embodiment 1
The dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
A kind of dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection, this test kit Including:
1) test reaction cup, its endoperidium has Streptavidin, connection to have biotinylation gamma interferon monoclonal antibody, And containing europium labelling gamma interferon monoclonal antibody;
2) calibration object reaction cup, its endoperidium has Streptavidin, connection to have biotinylation gamma interferon monoclonal anti Body, and containing europium labelling gamma interferon monoclonal antibody and the calibration object of variable concentrations;Calibration object contains 0,6,300,15000pg/ The gamma interferon antigen of mL;
3) blank culture tube, it is contained within the heparin sodium of 15IU/mL blood, and inside is vacuum negative pressure condition;
4) test cultures pipe, its be contained within the heparin sodium of 15IU/mL blood and the Rv3874 (CFP-10) of 5 μ g/mL and The combination of Rv3875 (ESAT-6), and inside is vacuum negative pressure condition;
5) positive control culture tube, it is contained within the heparin sodium of 15IU/mL blood, and 10 μ g/mL phytohaemagglutinin L, and Inside is vacuum negative pressure condition;
6) test buffer, it is contained within the sodium chloride of 0.15mol/L, the tween 20 of 0.6mL/L, 30ppmPreservative, the 4-hydroxyethyl piperazine ethanesulfonic acid of 5mmol/L, pH7.8 of ethylenediaminetetraacetic acid of 100 μm ol/L Buffer;
7) concentrating washing liquid, it is contained within the sodium chloride of 1.125g/L, the tween 20 of 0.2mL/L, 30ppmThe tris-HCI buffer of the 50mmol/L of preservative, pH7.8.
The preparation method of described test reaction cup is: by dilute for the phosphate buffer of Streptavidin 50mmol/L, pH7.8 It is interpreted into optimum concentration 5 μ g/mL, takes 50 μ L and join in blank reaction cup, 2~8 DEG C of refrigerators are hatched (22 ± 2) h, washs 1 time. Biotinylation gamma interferon monoclonal antibody 50mmol/L, the phosphate buffer of pH7.8 is diluted to optimum concentration 5 μ g/mL, Take 50 μ L and join in the reaction cup being coated with Streptavidin, 2~8 DEG C of refrigerators in hatch (22 ± 2) h, wash 2 times.Then Being carefully added into 50 μ L sealing coat solution in each cup, dried overnight under (36 ± 1) DEG C, 5% damp condition, then at sealing coat On be carefully added into the europium labelling gamma interferon monoclonal antibody of 1 μ L the suitableeest working concentration 200ng/mL, immediately at the hot blast of 60 DEG C Under dry up, and vacuum is crossed and is moulded packaging, and 2~8 DEG C save backup.
Described sealing coat use sealing coat solution be the sodium chloride containing 0.12mol/L, the sodium azide of 0.38g/L, The cattle gamma Globulin of 10g/L, the bovine serum albumin of 50g/L, the trehalose of 50g/L, 0.8g/L aboriginal mouse IgG, 0.05g/L Degeneration mouse IgG, 2g/L casein, the trishydroxymethylaminomethane-salt of 50mmol/L, pH7.8 of heparin sodium of 37.5U/mL Acid.
The solution of dilution europium labelling gamma interferon monoclonal antibody therein be the sodium chloride containing 150mmol/L, The sodium azide of 0.5g/L, the deionization bovine serum albumin of 2g/L, three hydroxyls of 50mmol/L, pH7.8 of trehalose of 125g/L Aminomethane-hydrochloric acid.
Europium labelling gamma interferon method for preparing monoclonal antibody therein is that labelling is with in gamma interferon monoclonal antibody Liquid NAP-10 post be replaced as the carbonate buffer solution of 50mmol/L, pH9.0, and make the concentration of traget antibody reach 2~ 5mg/mL, and the 4-[2-(4-isothiocyanatophenyl) acetenyl]-2 of the europium with 3 times of quality, 6 pairs of { [double (carboxymethyl)-ammonia of N, N Base] methyl } pyridine reagent is blended in oscillation incubation (22 ± 2) h at 2~8 DEG C, reactant liquor 50mmol/L, pH 7.80 3 hydroxyl first Sepharose CL-6B post (1cm × 40cm) chromatography of base aminomethane-hydrochloride buffer balance, A280 monitoring is collected respectively Albumen eluting peak.
Wherein, the outer safety helmet color of blank culture tube is green;The outer safety helmet color of test cultures pipe is yellow Color;The outer safety helmet color of positive control culture tube is red.
The preparation method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The test kit preparation method of the present embodiment, comprises the following steps:
1) test reaction cup is prepared: use the dry reagent rapid time of the present embodiment tuberculosis infection T cell detection to differentiate glimmering The preparation method of the test reaction cup in light immunoassay kits is prepared;
2) reaction cup of calibration object is prepared: with United Kingdom National biological products assay institute (National Institute for Biological Standards and Control, NIBSC) the gamma interferon biological reference material of numbering 87/586 (1IU/mL ≈ 50pg/mL) for comparison, by Human Lymphobl Toid Interferon antigen step 1) in sealing coat solution be diluted to 0,6, The calibration object of 300,15000pg/mL, in step 1) on the basis of test reaction cup in europium labelling gamma interferon monoclonal Being carefully added into the calibration object of 10 μ L on antibody layer, dry up immediately under the hot blast of 60 DEG C, the every concentration of calibration object arranges 2 holes, and very Empty mistake moulds packaging, and 2~8 DEG C save backup.
3) blank culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 15IU/mL blood. Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and making negative pressure of vacuum in test tube is 1mL/ pipe.In the lid of culture tube contains Plug and its outer safety helmet of coupling, the outer safety helmet color of blank culture tube uses green.
4) test cultures pipe is prepared: in clean test tube (plastics or glass), add the heparin sodium of 15IU/mL blood, and The Rv3874 (CFP-10) of 5 μ g/mL and the combination of Rv3875 (ESAT-6).Full-automatic vacuum-pumping capping machine uprightly put into by test tube In, making negative pressure of vacuum in test tube is 1mL/ pipe.The lid of culture tube contains Nei Sai and it mates outer safety helmet, outer safety helmet color Use yellow.
5) positive control culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 15IU/mL blood, And 10 phytohaemagglutinin L of μ g/mL.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and in making test tube, negative pressure of vacuum is 1mL/ manages.The lid of culture tube contains Nei Sai and it mates outer safety helmet, and the outer safety helmet color of positive control culture tube uses Red.
6) test buffer is prepared: the 4-hydroxyethyl piperazine ethanesulfonic acid buffer of 5mmol/L, pH7.8 contains The sodium chloride of 0.15mol/L, the tween 20 of 0.6mL/L, 30ppmPreservative, the second two of 100 μm ol/L Amine tetraacethyl.It is distributed into semi-finished product.
7) preparation concentrates washing liquid: contain in the tris-HCI buffer of 50mmol/L, pH7.8 The sodium chloride of 1.125g/L, the tween 20 of 0.2mL/L, 30ppmPreservative.It is distributed into semi-finished product.
8) subpackage test buffer and concentration washing liquid;
9) label.
10) finished product assembles.
Above-mentioned steps products obtained therefrom subpackage is semi-finished product.Extract 3 parts out through specificity, elaboration, sensitivity and to stablize Property assay approval just can be assembled into tuberculosis infection T cell detection kit (release in vitro immunofluorescence).After being completed also Need to inspect by random samples qualified after just can dispatch from the factory.
The detection method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The detection method of the test kit of the present embodiment comprises the following steps:
1) release in vitro of human gamma-interferon
1. press blank pipe N, testing tube T and the order of positive control pipe P, extract respectively in 3 kinds of culture tubes or add Enter 1mL whole blood sample (heparin sodium or clarin anticoagulant), at once reverse mixing more than 6 times, make content in 3 kinds of culture tubes with Blood fully mixes;
2. above 3 kinds of culture tubes added with whole blood are put into 37 (± 1) DEG C constant incubator after blood collection in 4 hours Middle cultivation 16~24 hours.Incubation keep culture tube upright.
3. cultivate after terminating, culture tube is centrifuged 10min with the rotating speed of 3000~5000r/min, takes blood plasma for inspection Survey the concentration of gamma interferon in each culture tube.Not disturbance hemocyte is it must be particularly noted that when drawing plasma sample.As can not Detection in time, it is necessary to supernatant blood plasma is taken out from culture tube, is placed in the clean centrifuge tube of 1.5mL, deposits 7 days for 2~8 DEG C, long Phase storage should preserve under the conditions of at least-20 DEG C, and number of freezing and thawing should be not higher than 3 times.
2) detection by quantitative of human gamma-interferon
(1) reagent prepares
Test reaction cup and the calibration object reaction cup of reagent and requirement are balanced to room temperature (20~25 DEG C).Remaining It is airtight and in 2~8 DEG C of preservations that reaction cup inserts valve bag in time.
(2) test operation
1. the calibration object of every concentration presets 2 holes, adds 30 μ L test buffer (calibration object concentration in calibration object reaction cup Become 0,2,100,5000pg/mL), the test buffer drawing 10 μ L samples and absorption 20 μ l is sequentially added into test reaction cup In.
2. reaction cup is at 37 DEG C, oscillation incubation 10min.
3., after hatching end, wash 4 times with cleaning mixture.
4. under 60 DEG C of hot blasts, it is dried 35s.
5. time-resolved fluorescence immunoassay instrument is used to carry out fluorescent value analysis of accounts.Fig. 1 be test kit of the present invention γ- Interferon detection by quantitative dose-response curve.
Embodiment 2
The dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
A kind of dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection, this test kit Including:
1) test reaction cup, its endoperidium has Streptavidin, biotinylation gamma interferon monoclonal antibody and europium labelling Gamma interferon monoclonal antibody;
2) calibration object reaction cup, with embodiment 1;
3) blank culture tube, it is contained within the clarin of 9.8IU/mL blood, and inside is vacuum negative pressure condition;
4) test cultures pipe, its be contained within the clarin of 9.8IU/mL blood and the Rv3874 (CFP-10) of 1 μ g/mL and The chimeric recombinant antibody of Rv3875 (ESAT-6), and inside is vacuum negative pressure condition;
5) positive control culture tube, it is contained within the clarin of 9.8IU/mL blood, and 1 μ g/mL ConA , and inside is vacuum negative pressure condition (ConA);
6) test buffer, with embodiment 1;
7) washing liquid is concentrated, with embodiment 1.
The preparation method of described test reaction cup is: by dilute for the phosphate buffer of Streptavidin 50mmol/L, pH7.8 It is interpreted into optimum concentration 0.1 μ g/mL, takes 50 μ L and join in blank reaction cup, 2~8 DEG C of refrigerators are hatched (22 ± 2) h, washs 1 Secondary.Biotinylation gamma interferon monoclonal antibody 50mmol/L, the phosphate buffer of pH7.8 is diluted to optimum concentration 0.1 μ G/mL, takes 50 μ L and joins in the reaction cup being coated with Streptavidin, 2~8 DEG C of refrigerators in hatch (22 ± 2) h, wash 2 times. The most each cup is carefully added into 50 μ L sealing coat solution, dried overnight under (36 ± 1) DEG C, 5% damp condition, then every The europium labelling gamma interferon monoclonal antibody of 1 μ L the suitableeest working concentration 100ng/mL it is carefully added into, immediately at 60 DEG C on absciss layer Drying up under hot blast, and vacuum is crossed and moulded packaging, 2~8 DEG C save backup.
The sealing coat solution that described sealing coat uses is with embodiment 1.
The solution of dilution europium labelling gamma interferon monoclonal antibody therein is with embodiment 1.
Europium labelling gamma interferon method for preparing monoclonal antibody therein is with embodiment 1.
Wherein, the outer safety helmet color of blank culture tube is green;The outer safety helmet color of test cultures pipe is yellow Color;The outer safety helmet color of positive control culture tube is red.
The preparation method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The test kit preparation method of the present embodiment, comprises the following steps:
1) test reaction cup is prepared: use the dry reagent rapid time of the present embodiment tuberculosis infection T cell detection to differentiate glimmering The preparation method of the test reaction cup in light immunoassay kits is prepared;
2) reaction cup of calibration object is prepared: with embodiment 1.
3) blank culture tube is prepared: in clean test tube (plastics or glass), add the heparin of 9.8IU/mL blood Potassium.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and making negative pressure of vacuum in test tube is 1mL/ pipe.The lid of culture tube contains Interior plug and its outer safety helmet of coupling, the outer safety helmet color of blank culture tube uses green.
4) test cultures pipe is prepared: in clean test tube (plastics or glass), add the clarin of 9.8IU/mL blood, with And 1 μ g/mL Rv3874 (CFP-10) and the chimeric recombinant antibody of Rv3875 (ESAT-6).Test tube is uprightly put into and is automatically taken out very In empty capping machine, making negative pressure of vacuum in test tube is 1mL/ pipe.The lid of culture tube contains Nei Sai and it mates outer safety helmet, outer peace Full cap color uses yellow.
5) positive control culture tube is prepared: in clean test tube (plastics or glass), add the heparin of 9.8IU/mL blood Potassium, and the ConA (ConA) of 1 μ g/mL.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, makes vacuum in test tube Negative pressure is 1mL/ pipe.The lid of culture tube contains Nei Sai and it mates outer safety helmet, the outer safety helmet face of positive control culture tube Color uses redness.
6) test buffer is prepared: with embodiment 1.
7) preparation concentrates washing liquid: with embodiment 1.
8) subpackage test buffer and concentration washing liquid;
9) label.
10) finished product assembles.
Above-mentioned steps products obtained therefrom subpackage is semi-finished product.Extract 3 parts out through specificity, elaboration, sensitivity and to stablize Property assay approval just can be assembled into tuberculosis infection T cell detection kit (release in vitro immunofluorescence).After being completed also Need to inspect by random samples qualified after just can dispatch from the factory.
The detection method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The detection method of the test kit of the present embodiment is with embodiment 1.
Embodiment 3
The dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
A kind of dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection, this test kit Including:
1) test reaction cup, its endoperidium has Streptavidin, biotinylation gamma interferon monoclonal antibody and europium labelling Gamma interferon monoclonal antibody;
2) calibration object reaction cup, with embodiment 1;
3) blank culture tube, it is contained within the heparin sodium of 28IU/mL blood, and inside is vacuum negative pressure condition;
4) test cultures pipe, its heparin sodium being contained within 28IU/mL blood and the Rv0733 of 10 μ g/mL, and inside is vacuum Negative pressure state;
5) positive control culture tube, it is contained within the heparin sodium of 28IU/mL blood, and 20 μ g/mL ConAs , and inside is vacuum negative pressure condition (ConA);
6) test buffer, with embodiment 1;
7) washing liquid is concentrated, with embodiment 1.
The preparation method of described test reaction cup is: by dilute for the phosphate buffer of Streptavidin 50mmol/L, pH7.8 It is interpreted into optimum concentration 10 μ g/mL, takes 50 μ L and join in blank reaction cup, 2~8 DEG C of refrigerators are hatched (22 ± 2) h, washs 1 Secondary.Biotinylation gamma interferon monoclonal antibody 50mmol/L, the phosphate buffer of pH7.8 is diluted to optimum concentration 10 μ g/ ML, takes 50 μ L and joins in the reaction cup being coated with Streptavidin, 2~8 DEG C of refrigerators in hatch (22 ± 2) h, wash 2 times.So Being carefully added into 50 μ L sealing coat solution in rear each cup, dried overnight under (36 ± 1) DEG C, 5% damp condition, then in isolation The europium labelling gamma interferon monoclonal antibody of 1 μ L the suitableeest working concentration 400ng/mL it is carefully added into, immediately the heat of 60 DEG C on layer Drying up under wind, and vacuum is crossed and moulded packaging, 2~8 DEG C save backup.
The sealing coat solution that described sealing coat uses is with embodiment 1.
The solution of dilution europium labelling gamma interferon monoclonal antibody therein is with embodiment 1.
Europium labelling gamma interferon method for preparing monoclonal antibody therein is with embodiment 1.
Wherein, the outer safety helmet color of blank culture tube is green;The outer safety helmet color of test cultures pipe is yellow Color;The outer safety helmet color of positive control culture tube is red.
The preparation method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The test kit preparation method of the present embodiment, comprises the following steps:
1) test reaction cup is prepared: use the dry reagent rapid time of the present embodiment tuberculosis infection T cell detection to differentiate glimmering The preparation method of the test reaction cup in light immunoassay kits is prepared;
2) reaction cup of calibration object is prepared: with embodiment 1.
3) blank culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 28IU/mL blood. Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and making negative pressure of vacuum in test tube is 1mL/ pipe.In the lid of culture tube contains Plug and its outer safety helmet of coupling, the outer safety helmet color of blank culture tube uses green.
4) test cultures pipe is prepared: in clean test tube (plastics or glass), add the heparin sodium of 28IU/mL blood, and The Rv0733 of 10 μ g/mL.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and making negative pressure of vacuum in test tube is 1mL/ pipe.Training The lid supporting pipe contains Nei Sai and its outer safety helmet of coupling, and outer safety helmet color uses yellow.
5) positive control culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 28IU/mL blood, And 20 ConAs (ConA) of μ g/mL.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and in making test tube, vacuum is born Press and manage for 1mL/.The lid of culture tube contains Nei Sai and it mates outer safety helmet, the outer safety helmet color of positive control culture tube Use redness.
6) test buffer is prepared: with embodiment 1.
7) preparation concentrates washing liquid: with embodiment 1.
8) subpackage test buffer and concentration washing liquid;
9) label.
10) finished product assembles.
Above-mentioned steps products obtained therefrom subpackage is semi-finished product.Extract 3 parts out through specificity, elaboration, sensitivity and to stablize Property assay approval just can be assembled into tuberculosis infection T cell detection kit (release in vitro immunofluorescence).After being completed also Need to inspect by random samples qualified after just can dispatch from the factory.
The detection method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The detection method of the test kit of the present embodiment is with embodiment 1.
Embodiment 4
The dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
A kind of dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection, this test kit Including:
1) test reaction cup, its endoperidium has Streptavidin, biotinylation gamma interferon monoclonal antibody and europium labelling Gamma interferon monoclonal antibody;
2) calibration object reaction cup, with embodiment 1;
3) blank culture tube, it is contained within the clarin of 20IU/mL blood, and inside is vacuum negative pressure condition;
4) test cultures pipe, its clarin being contained within 20IU/mL blood and the Rv1978 of 6 μ g/mL, Rv1980, The compositions of Rv1981c, Rv1984, Rv1985c and Rv2654c, and inside is vacuum negative pressure condition;
5) positive control culture tube, it is contained within the clarin of 20IU/mL blood, and 12 μ g/mL ConAs , and inside is vacuum negative pressure condition (ConA);
6) test buffer, with embodiment 1;
7) washing liquid is concentrated, with embodiment 1.
The preparation method of described test reaction cup is: by dilute for the phosphate buffer of Streptavidin 50mmol/L, pH7.8 It is interpreted into optimum concentration 6 μ g/mL, takes 50 μ L and join in blank reaction cup, 2~8 DEG C of refrigerators are hatched (22 ± 2) h, washs 1 time. Biotinylation gamma interferon monoclonal antibody 50mmol/L, the phosphate buffer of pH7.8 is diluted to optimum concentration 6 μ g/mL, Take 50 μ L and join in the reaction cup being coated with Streptavidin, 2~8 DEG C of refrigerators in hatch (22 ± 2) h, wash 2 times.Then Being carefully added into 50 μ L sealing coat solution in each cup, dried overnight under (36 ± 1) DEG C, 5% damp condition, then at sealing coat On be carefully added into the europium labelling gamma interferon monoclonal antibody of 1 μ L the suitableeest working concentration 300ng/mL, immediately at the hot blast of 60 DEG C Under dry up, and vacuum is crossed and is moulded packaging, and 2~8 DEG C save backup.
The sealing coat solution that described sealing coat uses is with embodiment 1.
The solution of dilution europium labelling gamma interferon monoclonal antibody therein is with embodiment 1.
Europium labelling gamma interferon method for preparing monoclonal antibody therein is with embodiment 1.
Wherein, the outer safety helmet color of blank culture tube is green;The outer safety helmet color of test cultures pipe is yellow Color;The outer safety helmet color of positive control culture tube is red.
The preparation method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The test kit preparation method of the present embodiment, comprises the following steps:
1) test reaction cup is prepared: use the dry reagent rapid time of the present embodiment tuberculosis infection T cell detection to differentiate glimmering The preparation method of the test reaction cup in light immunoassay kits is prepared;
2) reaction cup of calibration object is prepared: with embodiment 1.
3) blank culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 20IU/mL blood. Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and making negative pressure of vacuum in test tube is 1mL/ pipe.In the lid of culture tube contains Plug and its outer safety helmet of coupling, the outer safety helmet color of blank culture tube uses green.
4) test cultures pipe is prepared: in clean test tube (plastics or glass), add the heparin sodium of 20IU/mL blood, and The compositions of Rv1978, Rv1980c, Rv1981c, Rv1984c, Rv1985c and Rv2654c of 6 μ g/mL.Test tube is uprightly put into In full-automatic vacuum-pumping capping machine, making negative pressure of vacuum in test tube is 1mL/ pipe.The lid of culture tube contains outside Nei Sai and its coupling Safety helmet, outer safety helmet color uses yellow.
5) positive control culture tube is prepared: in clean test tube (plastics or glass), add the heparin sodium of 20IU/mL blood, And 12 ConAs (ConA) of μ g/mL.Test tube is uprightly put in full-automatic vacuum-pumping capping machine, and in making test tube, vacuum is born Press and manage for 1mL/.The lid of culture tube contains Nei Sai and it mates outer safety helmet, the outer safety helmet color of positive control culture tube Use redness.
6) test buffer is prepared: with embodiment 1.
7) preparation concentrates washing liquid: with embodiment 1.
8) subpackage test buffer and concentration washing liquid;
9) label.
10) finished product assembles.
Above-mentioned steps products obtained therefrom subpackage is semi-finished product.Extract 3 parts out through specificity, elaboration, sensitivity and to stablize Property assay approval just can be assembled into tuberculosis infection T cell detection kit (release in vitro immunofluorescence).After being completed also Need to inspect by random samples qualified after just can dispatch from the factory.
The detection method of the dry reagent rapid time resolved fluorometric immunoassay kits of tuberculosis infection T cell detection
The detection method of the test kit of the present embodiment is with embodiment 1.
Embodiment 5
The positive cutoff value of the test kit of the present invention or the checking of reference interval
The positive cutoff value of tuberculosis infection T cell detection kit (release in vitro immunofluorescence) prepared by the present invention, With reference to People's Republic of China's inspection and quarantining for import/export industry standard SN/T 3312-2012 mycobacterium tuberculosis gamma interferon Result decision method in external detection method carries out interpretation, its interpretation method such as table 1.
Result decision method in table 1 mycobacterium tuberculosis gamma interferon external detection method
Note: the concentration of gamma interferon during N is blank pipe N in table, P is the dense of gamma interferon in positive control pipe P Degree, T is the concentration of gamma interferon in testing tube T.
Checking test: collect whole blood sample totally 448 example.Wherein sample type is as follows: (1) passes through sputum smear or expectorant Liquid cultivates the venous blood of the experimenter being defined as active tuberculosis, 77 examples;(2) feminine gender cultivated by sputum smear and sputum, but (before and after diagnostic treatment, two chest films showed are effective by other means;Bronchial perfusate, chest X-ray inspection, pathology Check, PPD strong positive person have two positives) venous blood of the person that confirms as m tuberculosis infection, 80 parts;(3) in pressing Medical association of China clinic diagnosis guide tuberculosis fascicle requires the venous blood of the experimenter of the outer tuberculosis of lung of clinical definite, 25 examples; (4) pulmonary carcinoma, non-tuberculosis respiratory tract disease and make a definite diagnosis other diseases patient 114 example;Chlamydia infection 5 example, pregnant 7 examples;(5) through asking Volume investigation is from tubercule bacillus low exposure crowd, and all without clinical symptoms, without tuberculosis contact history, chest X-ray is normal, Healthy population 134 example of having a medical check-up that tuberculin test is negative;(5) outpatient service follow-up case 7 example.Result such as table 2~table 3.According to The result interpretation method of upper industry standard, with clinical diagnosis for " goldstandard ", the positive coincidence rate of tuberculosis group is 99.45%, The negative match-rate of non-tuberculosis group is 96.54%, meets the gamma interferon release in vitro method of the tuberculosis infection T cell of report The requirement of method of quality control: positive reference material coincidence rate is not less than 75%, and negative reference product coincidence rate is for being not less than 75%. Interpretation knot can be carried out according to the result decision method in the mycobacterium tuberculosis gamma interferon external detection method of industry standard Really.
The distribution of results situation of table 2 448 example sample
The result accordance of table 3 448 example sample
Embodiment 6
The analytical performance evaluation index of the test kit of the present invention
The Performance Evaluating Indexes of the tuberculosis infection T cell detection kit (release in vitro immunofluorescence) of the present invention is such as Under:
1. blank limit: Parallel testing calibration object A 10 hole, calculates average (x) and the standard deviation (s) of its detection fluorescent value, profit Calculating concentration value corresponding to " x+2s " with dose-response curve to limit for blank, blank limit is better than 2pg/mL.
2. negative reference product coincidence rate: detect 20 parts of fresh peripheral anticoagulants without the healthy volunteer of tuberculosis clinical symptoms Blood sample, its negative reference product coincidence rate should be not less than 80%.Specific requirement: the healthy volunteer without tuberculosis clinical symptoms should Comprise different grades of tuberculin skin test crowd, i.e. should comprise tuberculin skin test strong positive person (72h scleroma or blush diameter >=15mm or with blister), tuberculin skin test positive (72h scleroma or blush diameter >=5mm) and tuberculin skin test the moon Property person (72h scleroma or blush diameter < 5mm) this 3 type.
3. positive reference material coincidence rate: detect 10 parts of mycobacterium tuberculosis smears and (or) cultivate positive tuberculosis patient The fresh peripheral anticoagulation sample of (bacterium sun) and 10 parts of mycobacterium tuberculosis smears and (or) cultivate negative clinical definite tuberculosis The fresh peripheral anticoagulation sample of patient's (bacterium is cloudy), its positive reference material coincidence rate should be not less than 80%.
4. precision: after application positive stimulus, blood plasma or enterprise's elaboration reference material detect as sample, parallel Testing 10 holes, calculate the coefficient of variation (CV) value of concentration value, in batch, CV value should be not higher than 10.0%.3 batches of quantity-produced Between test kit batch between CV value should be not higher than 20.0%.
The most linear: in the 2~5000pg/mL ranges of linearity, linearly dependent coefficient r should be not less than 0.9900.
6. accuracy: in the range of test kit calibration object B~F, with the test kit supporting calibration object detection world after calibration The relative deviation of reference material or enterprise's reference material, the measured value of reference material and sign value should be in the range of ± 20.0%.
7. stability: preserve to finished product effect duration 2 months interior samples under the conditions of physical holding of the stock to blank limit, feminine gender The indexs such as reference material coincidence rate, positive reference material coincidence rate, withinrun precision, linear and accuracy detect, testing result Meet requirements above.
Embodiment 7
The interference test evaluation of the test kit of the present invention
The analysis Evaluation on specificity of the tuberculosis infection T cell detection kit (release in vitro immunofluorescence) of the present invention is such as Under:
Detection is following disturbs sample, all without there is false positive or false negative result.Bilirubin 818 μm ol/L, hemoglobin 180g/L, the triglyceride 21.54mmol/L noiseless effect of testing result to this test kit.
Table 4 disturbs Sample size
Embodiment 8
The test kit of the present invention and the equivalence evaluation of reference kit
The equivalence of tuberculosis infection T cell detection kit (release in vitro immunofluorescence) prepared by the present invention is evaluated such as Under:
In 340 example clinical trial samples, include 165 examples through living that the Diagnosis of Tuberculosis standard that this clinical trial specifies is made a definite diagnosis Institute's tubercular's sample, 25 example outpatient service samples, 70 example pulmonary carcinoma and non-tuberculosis respiratory disease patient sample, 40 examples are had a medical check-up Healthy People Sample, 40 example high-risk group's samples.With clinical diagnosis as goldstandard, reagent to be evaluated tuberculosis group sensitivity up to 85.71%, the specificity in non-tuberculosis and healthy population is up to 84.43%, and thick concordance rate is up to 85.19%.With Beijing ten thousand The tuberculosis infection T cell detection kit (release in vitro euzymelinked immunosorbent assay (ELISA)) that safe biological Pharmaceutical limited company produces is comparison Reagent, the results detailed in Table 5 and table 6.
Table 5 sample type and recall rate
Table 6 reagent to be evaluated and contrast agents testing result compare
Test kit to be evaluated has positive implicative (r with contrast agents box detection clinical sample resultp=0.70);Positive symbol Conjunction rate reaches 100%;Negative match-rate reaches 98.11%;Total coincidence rate P0It is 99.12%;Kappa index is 0.9824, for height Unanimously (κ > 0.75), it is believed that two system equivalences;The positive rate result difference of reagent to be evaluated and contrast agents is without statistics Meaning (χ2=1.33 < 3.84, P > 0.05), it is believed that the assay of two kinds of methods is consistent.3 example reagent to be evaluated are with right The sample not being inconsistent according to reagent, 1 example reagent to be evaluated is positive and specimen that contrast agents is negative is bacterium the moon pulmonary tuberculosis group patient in hospital Sample, 2 example reagent to be evaluated are negative and specimen that contrast agents is positive is high-risk group person's sample, and reagent diplopore to be evaluated is rechecked Result meets with result of the test for the first time, and PPD skin test is strong positive, but expectorant bacterium smear testing result is negative, and chest x-ray is examined Look into no abnormality seen, may be latent tuberculosis mycobacterial infections person.Square grids table is set up, such as table 7 according to clinical test results.
The contrast test evaluation result of 7 340 parts of clinical trial samples of table
The present invention uses dry reagent rapid time resolved fluorometric immuno analytical method, solves conventional Conventional Time and differentiates Fluorescence immunoassay technology reagent component is various, and liquid reagent is not sufficiently stable, complex operation, the longest shortcoming.And this Invention solves during conventional tuberculosis infection T cell measures needs independent blood taking tube and culture tube, trivial operations, easily go out The shortcomings such as mistake, automaticity are the highest;Present invention achieves blood taking tube and culture tube integration, negative pressure of vacuum is accurately taken a blood sample;3 kinds Culture tube uses different colours label and cap to make a distinction;Avoid during whole blood cell culture blood taking tube uncap, subpackage blood sample, The processes such as secondary marker, it is therefore prevented that sample is uncapped at blood taking tube, secondary pollution during subpackage blood sample, during decreasing this Potential bio-safety risk, also prevent secondary marker process produce mistake, as long as and after whole blood cell culture routinely from I.e. can be placed in after the heart and on fully automatic system, be sampled detection, reduce working strength and improve work efficiency.The present invention Culture tube have blood taking tube and culture tube integration, blood collection procedure decreases consumptive material uses, vacuum is accurately taken a blood sample, be suitable to from The features such as dynamicization operation.The test kit of the present invention has testing result accuracy, highly sensitive, high specificity, good stability, inspection The features such as survey method is easy, efficient, are suitable for real-time test (point-of-care testing, POCT).
Last institute is it should be noted that, the present invention is only protected by above example in order to technical scheme to be described Protecting the restriction of scope, although being explained in detail the present invention with reference to preferred embodiment, those of ordinary skill in the art should Understand, technical scheme can be modified or equivalent, without deviating from the essence of technical solution of the present invention And scope.

Claims (10)

1. the rapid time resolved fluorometric immunoassay kits being applicable to the detection of tuberculosis infection T cell, it is characterised in that: Including: 1) test reaction cup, its endoperidium has Streptavidin and the biotinylation γ-interference being combined on Streptavidin Element monoclonal antibody, and the gamma interferon monoclonal antibody containing lanthanide series labelling;2) calibration object reaction cup, its endoperidium There are Streptavidin and the biotinylation gamma interferon monoclonal antibody being combined on Streptavidin, and containing europium labelling Gamma interferon monoclonal antibody and the calibration object of variable concentrations;3) blank culture tube, it is contained within anticoagulative substance;4) Test cultures pipe, it is contained within anticoagulative substance and antigen of mycobacterium tuberculosis specific T-cells can be stimulated to produce γ-interference The stimulus object of element, stimulus object be in the antigen of mycobacterium tuberculosis and derivative epitope peptide thereof and their analog extremely Few one;5) positive control culture tube, it is contained within anticoagulative substance and cell agglutinin;6) test buffer;And 7) dense Contracting washing liquid.
Test kit the most according to claim 1, it is characterised in that: described stimulus object be mycobacterium tuberculosis Rv0733, Rv1978、Rv1980c、Rv1981c、Rv1984c、Rv1985c、Rv2654c、Rv3425、Rv3429、Rv3615c、Rv3873、 In Rv3874, Rv3875, Rv3878, Rv3879c antigen, their derivative epitope peptide, chimeric recombinant antigens and the like At least one.
Test kit the most according to claim 1, it is characterised in that: described stimulus object is the combination of Rv3874 and Rv3875.
Test kit the most according to claim 1, it is characterised in that: described anticoagulative substance is heparin sodium and/or Lithium acid heparin;
Described cell agglutinin is phytohemagglutinin and/or ConA.
Test kit the most according to claim 1, it is characterised in that: described test buffer is the chlorine containing 0.15mol/L Change sodium, the tween 20 of 0.6mL/L, 30ppmPreservative, the ethylenediaminetetraacetic acid of 100 μm ol/L The 4-hydroxyethyl piperazine ethanesulfonic acid buffer of 5mmol/L, pH7.8.
Test kit the most according to claim 1, it is characterised in that: described concentration washing liquid is the chlorination containing 1.125g/L Sodium, the tween 20 of 0.2mL/L, 30ppmThe trihydroxy methyl amino of 50 mmol/L of preservative, pH7.8 Methane-hydrochloride buffer.
Test kit the most according to claim 1, it is characterised in that: the preparation method of described test reaction cup is: by described Streptavidin is diluted to concentration 0.1~10 μ g/mL, joins in skip test reaction cup, hatches 20~24h at 2~8 DEG C, Washing;Described biotinylation gamma interferon monoclonal antibody is diluted to concentration 0.1~10 μ g/mL, joins and be coated with strepto- In the test reaction cup of Avidin, hatch 20~24h at 2~8 DEG C, washing;The most each cup adds sealing coat solution, is dried Rear formation sealing coat, to prevent the gamma interferon monoclonal antibody of lanthanide series labelling to be adsorbed onto on test reaction cup, finally exists The gamma interferon monoclonal antibody of the described lanthanide series labelling that working concentration is 100~400ng/mL is added on sealing coat, dry Described test reaction cup is i.e. obtained after dry.
Test kit the most according to claim 7, it is characterised in that: the sealing coat solution that described sealing coat uses is for containing The sodium chloride of 0.12mol/L, the sodium azide of 0.38g/L, the cattle gamma Globulin of 10g/L, the bovine serum albumin of 50g/L, 50g/L Trehalose, degeneration mouse IgG, 2g/L casein of 0.8g/L aboriginal mouse IgG, 0.05g/L, the heparin sodium of 37.5U/mL Trishydroxymethylaminomethane-the hydrochloric acid of 50mmol/L, pH7.8.
9. according to the rapid time resolved fluorometric being applicable to the detection of tuberculosis infection T cell according to any one of claim 1~8 The detection method of immunoassay kits, it is characterised in that: comprise the following steps:
(1) in blank culture tube, test cultures pipe and three kinds of culture tubes of positive control culture tube, whole blood is added respectively This, and reverse make the content in whole blood sample and three kinds of culture tubes mix for several times;
(2) three kinds of culture tubes added with whole blood sample are placed at 35~38 DEG C upright cultivation 16~24 hours;
(3), after cultivation terminates, by centrifugal, blood plasma in the whole blood sample of three kinds of culture tubes is separated;
(4) that presets in calibration object reaction cup is separately added into test buffer containing in the hole of the calibration object of variable concentrations, and By step 3) in blood plasma in the whole blood sample that separates and test buffer add in test reaction cup;
(5) by calibration object reaction cup and test reaction cup at 30~40 DEG C, oscillation incubation 5~20min;
(6) washing, dried, use time-resolved fluorescence immunoassay instrument to carry out fluorescent value counting.
Detection method the most according to claim 9, it is characterised in that: in described step (3), centrifugal refer to 3000~ 10~20min it are centrifuged under the rotating speed of 5000r/min;
In described step (6), it is dried and refers to be dried under 50~70 DEG C of hot blasts 30~40s.
CN201610392936.2A 2016-06-03 2016-06-03 Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit Pending CN106053783A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610392936.2A CN106053783A (en) 2016-06-03 2016-06-03 Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610392936.2A CN106053783A (en) 2016-06-03 2016-06-03 Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit

Publications (1)

Publication Number Publication Date
CN106053783A true CN106053783A (en) 2016-10-26

Family

ID=57170153

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610392936.2A Pending CN106053783A (en) 2016-06-03 2016-06-03 Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit

Country Status (1)

Country Link
CN (1) CN106053783A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108490189A (en) * 2018-03-14 2018-09-04 江苏瑞安生物技术有限公司 Detect the chromatography method and test strips preparation method of mycobacterium tuberculosis interferon
CN108548919A (en) * 2018-04-04 2018-09-18 广州市雷德生物科技有限公司 A kind of pre-coated elisa plate and its preparation method and application
CN110221063A (en) * 2019-07-03 2019-09-10 广州市丰华生物工程有限公司 A kind of rapid time resolved fluorometric immunoassay detection kit and its detection method
EP3619533B1 (en) 2017-05-05 2022-09-28 bioMérieux Method for detecting a cellular immune response

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429026B1 (en) * 1996-04-08 2002-08-06 Innotrac Diagnostics Oy One-step all-in-one dry reagent immunoassay
CN101221173A (en) * 2007-01-12 2008-07-16 中国人民解放军总医院第二附属医院 ELISpot tuberculosis infection diagnostic reagent kit and its application
CN101294964A (en) * 2007-11-27 2008-10-29 复旦大学附属华山医院 Reagent and method for detecting active tuberculosis and tuberculosis dormant infection
CN103063836A (en) * 2011-10-18 2013-04-24 复旦大学附属华山医院 Reagent, method and kit for detecting mycobacterial infection
CN103344630A (en) * 2013-08-09 2013-10-09 郑州安图生物工程股份有限公司 Kit for quantitatively detecting mycobacterium tuberculosis gamma interferon

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429026B1 (en) * 1996-04-08 2002-08-06 Innotrac Diagnostics Oy One-step all-in-one dry reagent immunoassay
CN101221173A (en) * 2007-01-12 2008-07-16 中国人民解放军总医院第二附属医院 ELISpot tuberculosis infection diagnostic reagent kit and its application
CN101294964A (en) * 2007-11-27 2008-10-29 复旦大学附属华山医院 Reagent and method for detecting active tuberculosis and tuberculosis dormant infection
CN103063836A (en) * 2011-10-18 2013-04-24 复旦大学附属华山医院 Reagent, method and kit for detecting mycobacterial infection
CN103344630A (en) * 2013-08-09 2013-10-09 郑州安图生物工程股份有限公司 Kit for quantitatively detecting mycobacterium tuberculosis gamma interferon

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SHARON PERRY 等: "Reproducibility of QuantiFERON-TB Gold In-Tube Assay", 《CLINICAL AND VACCINE IMMUNOLOGY》 *
王云双 赵英剑 刘永杰 主编: "《临床免疫学检验》", 31 March 2009, 军事医学科学出版社 *
肖克宇 主编: "《水产动物免疫学》", 30 June 2011, 中国农业出版社 *
额尔敦 等: "γ-干扰素时间分辨免疫荧光分析方法的建立", 《生物化学与生物物理进展》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3619533B1 (en) 2017-05-05 2022-09-28 bioMérieux Method for detecting a cellular immune response
CN108490189A (en) * 2018-03-14 2018-09-04 江苏瑞安生物技术有限公司 Detect the chromatography method and test strips preparation method of mycobacterium tuberculosis interferon
CN108548919A (en) * 2018-04-04 2018-09-18 广州市雷德生物科技有限公司 A kind of pre-coated elisa plate and its preparation method and application
CN110221063A (en) * 2019-07-03 2019-09-10 广州市丰华生物工程有限公司 A kind of rapid time resolved fluorometric immunoassay detection kit and its detection method

Similar Documents

Publication Publication Date Title
CN101365949A (en) Detection of tuberculosis and infection by mycobacterium tuberculosis using HBBA
CN101923091B (en) Kit for detecting high-sensitivity mycobacterium tuberculosis
CN104628833B (en) A kind of tuberculosis infection cellular immunization detectable antigens composition and application thereof
CN106018800B (en) A kind of detection device of Infected with Brucella
CN106053783A (en) Quick time-resolved fluorescence immunoassay kit for detection of T cells infected with tuberculosis and detection method of kit
JP2004529350A (en) Candida Detection
CN104020297B (en) Test kit for m tuberculosis infection detection and clinical therapeutic efficacy monitoring and application thereof
CN105067812A (en) Bovine brucella indirect ELISA antibody detection kit
Flaherty et al. Multilaboratory comparison of three immunodiffusion methods used for the detection of precipitating antibodies in hypersensitivity pneumonitis
AU2020210232A1 (en) Inert vector Escherichia coli and potential use thereof
CN105388300B (en) Tuberculosis immunodiagnosis molecular marker and vaccine use thereof
CN109182167B (en) Production process of high titer tuberculin skin test diagnostic reagent (PPD)
CN107219362A (en) Antigen, kit and application for detecting tuberculosis infection T cell
Soufleris et al. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents
CN108490189A (en) Detect the chromatography method and test strips preparation method of mycobacterium tuberculosis interferon
Yang et al. Expert consensus-based laboratory testing of SARS-CoV-2
Affronti et al. Serodiagnostic test for tuberculosis
CN107144694A (en) Antigen, kit and application for detecting tuberculosis infection T cell
CN105759038A (en) Immunoassay method and kit for assaying mycobacterium tuberculosis from biological samples
Rivetz et al. Evaluation of a novel rapid kit for the visual detection of Newcastle disease virus antibodies
CN113717258B (en) Antigen polypeptide composition for immune detection of SARS-CoV-2 infected cells, application and kit thereof
CN109991417A (en) A kind of immunological marker object lungy and application
RU2503005C1 (en) Diagnostic technique for pulmonary tuberculosis
CN110221063A (en) A kind of rapid time resolved fluorometric immunoassay detection kit and its detection method
CN104628834B (en) A kind of tuberculosis infection T cell immunodetection antigen and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161026

RJ01 Rejection of invention patent application after publication